Carbamazepine: Difference between revisions

From SEHK Wiki
Helen (talk | contribs)
No edit summary
Helen (talk | contribs)
Line 23: Line 23:
''By rectum'': for short-term use (Max. 7 days) when oral therapy temporarily not possible; 125-mg suppository approximately equivalent to 100-mg tablet, but final adjustment should always depend on clinical response. Max. 1 g daily in 4 divided doses.
''By rectum'': for short-term use (Max. 7 days) when oral therapy temporarily not possible; 125-mg suppository approximately equivalent to 100-mg tablet, but final adjustment should always depend on clinical response. Max. 1 g daily in 4 divided doses.
   
   
Elderly:  reduce initial dose.


Doses in children, for use as adjunctive therapy in children aged 6 years and over, and as monotherapy in those aged 12 years or over.
Child: the usual daily dose may be given according to age as follows:
*Up to 1 year: 100 to 200 mg
*1 to 5 years: 200 to 400 mg
*5 to 10 years: 400 to 600 mg
*10 to 15 years: 0.6 to 1 g
*Over 15 years: usual adult doses


6-12 years (adjunctive therapy):
The maximum recommended daily dose, according to age, is as follows:
 
*Up to 6 years: 35 mg/kg
*initially 10 mg/kg (max. 300 mg) once daily on day 1, then
*6 to 15 years: 1 g
*10 mg /kg (max. 300mg) twice daily on day 2, then
*Over 15 years: 1.2 g
*10mg mg/kg (max. 300 mg) 3 times daily on day 3;
*Usual dose 25 – 35 mg/kg daily in 3 divided doses;
*Max. 70 mg/kg daily in 3 divided doses.


|-
|-

Revision as of 21:41, 7 October 2020

Carbamazepine(中文: 卡馬西平) is an anticonvulsant medication used primarily in the treatment of epilepsy and neuropathic pain. Carbamazepine appears to work as well as phenytoin and valproate for focal and generalized seizures. It is not effective for absence or myoclonic seizures. It is used in schizophrenia and as a second-line agent in the management of bipolar disorder unresponsive to lithium.

Drug Names

Generic Name 藥名 HA Code 藥物代碼 Classification藥物分類
Carbamazepine Suspension 100mg/5ml CARB49 P1S1S3

Mechanism of Action

Anticonvulsant medication. It is a sodium channel blocker. It binds to sodium channels and suppresses repetitive neuronal firing.

Dosage

Epilepsy Oral: initially 100 – 200 mg 1-2 times daily, increased slowly by increments of up 200 mg daily every week to an usual maintenance dose of 0.8 – 1.2 g daily in divided doses; up to 2 g daily may occasionally be necessary.

By rectum: for short-term use (Max. 7 days) when oral therapy temporarily not possible; 125-mg suppository approximately equivalent to 100-mg tablet, but final adjustment should always depend on clinical response. Max. 1 g daily in 4 divided doses.

Elderly: reduce initial dose.

Child: the usual daily dose may be given according to age as follows:

  • Up to 1 year: 100 to 200 mg
  • 1 to 5 years: 200 to 400 mg
  • 5 to 10 years: 400 to 600 mg
  • 10 to 15 years: 0.6 to 1 g
  • Over 15 years: usual adult doses

The maximum recommended daily dose, according to age, is as follows:

  • Up to 6 years: 35 mg/kg
  • 6 to 15 years: 1 g
  • Over 15 years: 1.2 g
Neuropathic Pain By mouth:
  • 300 mg once daily on day 1, then
  • 300 mg twice daily on day 2, then
  • 300 mg 3 times daily on day 3.

Alternatively, 300 mg 3 times daily on day 1, then increased according to response in steps of 300mg (in 3 divided doses) every 2-3 days up to max. 3.6 g daily.

Migraine prophylaxis By mouth:
  • initially 300 mg daily, increased according to response up to 2.4 g daily in divided doses.